Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 25 items for :

  • methylprednisolone x
Clear All
Katica Bajuk Studen Department of Nuclear Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Search for other papers by Katica Bajuk Studen in
Google Scholar
PubMed Close
,
Simona Gaberšček Department of Nuclear Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Search for other papers by Simona Gaberšček in
Google Scholar
PubMed Close
,
Edvard Pirnat Department of Nuclear Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia

Search for other papers by Edvard Pirnat in
Google Scholar
PubMed Close
,
Nataša Bedernjak Bajuk Department of Nuclear Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia

Search for other papers by Nataša Bedernjak Bajuk in
Google Scholar
PubMed Close
,
Andreja Vendramin Department of Nuclear Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia

Search for other papers by Andreja Vendramin in
Google Scholar
PubMed Close
,
Vito Majcen Department of Nuclear Medicine, SB Celje, Celje, Slovenia

Search for other papers by Vito Majcen in
Google Scholar
PubMed Close
, and
Katja Zaletel Department of Nuclear Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Search for other papers by Katja Zaletel in
Google Scholar
PubMed Close

additional cortisol if needed ( 14 ). In accordance with this, a 30-day treatment protocol with a starting dose of 24 mg/day of methylprednisolone (MPSL) as the initial treatment for ST and tapered by 4 mg every 5 days is employed in our center. The

Article Type:
Research Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-23-0054
Volume/Issue:
Volume 12: Issue 11
Open access
Lia Ferreira Department of Endocrinology, Centro Hospitalar do Porto, Porto, Portugal

Search for other papers by Lia Ferreira in
Google Scholar
PubMed Close
,
João Silva Department of Endocrinology, Hospital das Forças Armadas, Lisboa, Portugal

Search for other papers by João Silva in
Google Scholar
PubMed Close
,
Susana Garrido Department of Endocrinology, Centro Hospitalar Tâmega e Sousa, Porto, Portugal

Search for other papers by Susana Garrido in
Google Scholar
PubMed Close
,
Carlos Bello Department of Endocrinology, Centro Hospitalar Lisboa Ocidental, Lisboa, Portugal

Search for other papers by Carlos Bello in
Google Scholar
PubMed Close
,
Diana Oliveira Department of Endocrinology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal

Search for other papers by Diana Oliveira in
Google Scholar
PubMed Close
,
Hélder Simões Department of Endocrinology, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal

Search for other papers by Hélder Simões in
Google Scholar
PubMed Close
,
Isabel Paiva Department of Endocrinology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal

Search for other papers by Isabel Paiva in
Google Scholar
PubMed Close
,
Joana Guimarães Department of Endocrinology, Centro Hospitalar do Baixo Vouga, Aveiro, Portugal

Search for other papers by Joana Guimarães in
Google Scholar
PubMed Close
,
Marta Ferreira Department of Endocrinology, Centro Hospitalar de Leiria, Leiria, Portugal

Search for other papers by Marta Ferreira in
Google Scholar
PubMed Close
,
Teresa Pereira Department of Endocrinology, Centro Hospitalar de Leiria, Leiria, Portugal

Search for other papers by Teresa Pereira in
Google Scholar
PubMed Close
,
Rita Bettencourt-Silva Department of Endocrinology, Centro Hospitalar de São João, Porto, Portugal

Search for other papers by Rita Bettencourt-Silva in
Google Scholar
PubMed Close
,
Ana Filipa Martins Department of Endocrinology, Centro Hospitalar Lisboa Norte, Lisboa, Portugal

Search for other papers by Ana Filipa Martins in
Google Scholar
PubMed Close
,
Tiago Silva Department of Endocrinology, Hospital Garcia da Orta, Lisboa, Portugal

Search for other papers by Tiago Silva in
Google Scholar
PubMed Close
,
Vera Fernandes Department of Endocrinology, Hospital de Braga, Braga, Portugal

Search for other papers by Vera Fernandes in
Google Scholar
PubMed Close
,
Maria Lopes Pereira Department of Endocrinology, Hospital de Braga, Braga, Portugal

Search for other papers by Maria Lopes Pereira in
Google Scholar
PubMed Close
, and
Adrenal Tumors Study Group of the Portuguese Society of Endocrinology Department of Endocrinology, Centro Hospitalar do Porto, Porto, Portugal

Search for other papers by Adrenal Tumors Study Group of the Portuguese Society of Endocrinology in
Google Scholar
PubMed Close

, 6.1% with dexamethasone and 0.7% methylprednisolone (missing data = 11). The mean daily dose for patients with hydrocortisone treatment was 26.3 ± 8.3 mg/day (missing data = 1), which was divided into one (3.5%), two (37.4%), three (57.5%) or four (0

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0295
Volume/Issue:
Volume 6: Issue 8
Open access
C E Higham Department of Endocrinology, Christie Hospital NHS Foundation Trust, Manchester, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK

Search for other papers by C E Higham in
Google Scholar
PubMed Close
,
A Olsson-Brown The Clatterbridge Cancer Centre, Bebbington, Wirral, UK
The University of Liverpool, Brownlow Hill, Liverpool, UK

Search for other papers by A Olsson-Brown in
Google Scholar
PubMed Close
,
P Carroll Department of Endocrinology, Guy’s & St. Thomas’ NHS Foundation Trust, London, UK

Search for other papers by P Carroll in
Google Scholar
PubMed Close
,
T Cooksley Department of Acute Medicine, UHSM and Christie Hospital NHS Foundation Trust, Manchester, UK

Search for other papers by T Cooksley in
Google Scholar
PubMed Close
,
J Larkin Skin Unit, Royal Marsden Hospital, London, UK

Search for other papers by J Larkin in
Google Scholar
PubMed Close
,
P Lorigan Department of Medical Oncology, Christie Hospital NHS Foundation Trust, Manchester, UK

Search for other papers by P Lorigan in
Google Scholar
PubMed Close
,
D Morganstein Department of Endocrinology, Chelsea and Westminster Hospital, London, UK

Search for other papers by D Morganstein in
Google Scholar
PubMed Close
,
P J Trainer Department of Endocrinology, Christie Hospital NHS Foundation Trust, Manchester, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK

Search for other papers by P J Trainer in
Google Scholar
PubMed Close
, and
the Society for Endocrinology Clinical Committee The Society for Endocrinology, Starling House, 1600 Bristol Parkway North, Bristol, UK

Search for other papers by the Society for Endocrinology Clinical Committee in
Google Scholar
PubMed Close

cortisol deficiency glucocorticoids should be continued and an endocrine opinion sought. It is crucial to obtain a good drug history with regards to recent glucocorticoid use to enable correct interpretation of results. Methylprednisolone is not an

Article Type:
Other
DOI:
https://doi.org/10.1530/EC-18-0068
Volume/Issue:
Volume 7: Issue 7
Open access
Arno Téblick Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium

Search for other papers by Arno Téblick in
Google Scholar
PubMed Close
,
Ilse Vanhorebeek Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium

Search for other papers by Ilse Vanhorebeek in
Google Scholar
PubMed Close
,
Inge Derese Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium

Search for other papers by Inge Derese in
Google Scholar
PubMed Close
,
An Jacobs Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium

Search for other papers by An Jacobs in
Google Scholar
PubMed Close
,
Renata Haghedooren Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium

Search for other papers by Renata Haghedooren in
Google Scholar
PubMed Close
,
Sofie Maebe Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium

Search for other papers by Sofie Maebe in
Google Scholar
PubMed Close
,
Gerdien A Zeilmaker-Roest Department of Neonatal & Pediatric Intensive Care, Division of Pediatric Intensive Care, Erasmus MC – Sophia Children’s Hospital, Rotterdam, the Netherlands

Search for other papers by Gerdien A Zeilmaker-Roest in
Google Scholar
PubMed Close
,
Enno D Wildschut Department of Neonatal & Pediatric Intensive Care, Division of Pediatric Intensive Care, Erasmus MC – Sophia Children’s Hospital, Rotterdam, the Netherlands

Search for other papers by Enno D Wildschut in
Google Scholar
PubMed Close
,
Lies Langouche Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium

Search for other papers by Lies Langouche in
Google Scholar
PubMed Close
, and
Greet Van den Berghe Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium

Search for other papers by Greet Van den Berghe in
Google Scholar
PubMed Close

. Endocrinology 2019 15 417 – 427 . ( https://doi.org/10.1038/s41574-019-0185-7 ) 8 Hill KD Kannankeril PJ Jacobs JP Baldwin HS Jacobs ML O'Brien SM Bichel DP Graham EM Blasiole B Resheidat A , et al. Methylprednisolone for heart surgery in

Article Type:
Research Article
Collections:
Adrenal
DOI:
https://doi.org/10.1530/EC-24-0078
Volume/Issue:
Volume 13: Issue 6
Open access
Yue-Yue Wang Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Search for other papers by Yue-Yue Wang in
Google Scholar
PubMed Close
,
Qian Wu Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Search for other papers by Qian Wu in
Google Scholar
PubMed Close
,
Lu Chen Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Search for other papers by Lu Chen in
Google Scholar
PubMed Close
,
Wen Chen Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Search for other papers by Wen Chen in
Google Scholar
PubMed Close
,
Tao Yang Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Search for other papers by Tao Yang in
Google Scholar
PubMed Close
,
Xiao-Quan Xu Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Search for other papers by Xiao-Quan Xu in
Google Scholar
PubMed Close
,
Fei-Yun Wu Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Search for other papers by Fei-Yun Wu in
Google Scholar
PubMed Close
,
Hao Hu Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Search for other papers by Hao Hu in
Google Scholar
PubMed Close
, and
Huan-Huan Chen Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Search for other papers by Huan-Huan Chen in
Google Scholar
PubMed Close

Glowczynska R Opolski G Kahaly G Bednarczuk T . Is high dose intravenous methylprednisolone pulse therapy in patients with Graves’ orbitopathy safe? Endokrynologia Polska 2014 65 402 – 413 . ( https://doi.org/10.5603/EP.2014.0056 ) 6 Mourits

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-21-0162
Volume/Issue:
Volume 10: Issue 7
Open access
Eva Novoa Department of Otorhinolaryngology, Clinic of Endocrinology, Head and Neck Surgery

Search for other papers by Eva Novoa in
Google Scholar
PubMed Close
,
Marcel Gärtner Department of Otorhinolaryngology, Clinic of Endocrinology, Head and Neck Surgery

Search for other papers by Marcel Gärtner in
Google Scholar
PubMed Close
, and
Christoph Henzen Department of Otorhinolaryngology, Clinic of Endocrinology, Head and Neck Surgery

Search for other papers by Christoph Henzen in
Google Scholar
PubMed Close

surgery. Furthermore, osteoporosis is a well-known side effect of systemic glucocorticoids, and short-term cumulative doses of 80–160 mg of methylprednisolone may also cause osteonecrosis (7) , a commonly overlooked complication. In the treatment of SSNHL

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-14-0076
Volume/Issue:
Volume 3: Issue 3
Open access
Brijesh Krishnappa Department of Endocrinology, K E M Hospital and Seth G S Medical College, Mumbai, India

Search for other papers by Brijesh Krishnappa in
Google Scholar
PubMed Close
,
Ravikumar Shah Department of Endocrinology, K E M Hospital and Seth G S Medical College, Mumbai, India

Search for other papers by Ravikumar Shah in
Google Scholar
PubMed Close
,
Saba Samad Memon Department of Endocrinology, K E M Hospital and Seth G S Medical College, Mumbai, India

Search for other papers by Saba Samad Memon in
Google Scholar
PubMed Close
,
Chakra Diwaker Department of Endocrinology, K E M Hospital and Seth G S Medical College, Mumbai, India

Search for other papers by Chakra Diwaker in
Google Scholar
PubMed Close
,
Anurag R Lila Department of Endocrinology, K E M Hospital and Seth G S Medical College, Mumbai, India

Search for other papers by Anurag R Lila in
Google Scholar
PubMed Close
,
Virendra A Patil Department of Endocrinology, K E M Hospital and Seth G S Medical College, Mumbai, India

Search for other papers by Virendra A Patil in
Google Scholar
PubMed Close
,
Nalini S Shah Department of Endocrinology, K E M Hospital and Seth G S Medical College, Mumbai, India

Search for other papers by Nalini S Shah in
Google Scholar
PubMed Close
, and
Tushar R Bandgar Department of Endocrinology, K E M Hospital and Seth G S Medical College, Mumbai, India

Search for other papers by Tushar R Bandgar in
Google Scholar
PubMed Close

(panhypophysitis)) AND ((steroid) OR (glucocorticoid) OR (corticoids) OR (predniso*) OR (corticoster*) OR (methylprednisolone) OR (conservatively) OR (conservative))’ as keywords with ‘humans’ and ‘English’ language filters. We further manually reviewed the

Article Type:
Research Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-22-0311
Volume/Issue:
Volume 12: Issue 2
Open access
Johan G Beun AdrenalNET, The Netherlands

Search for other papers by Johan G Beun in
Google Scholar
PubMed Close
,
Pia Burman Department of Endocrinology, Skåne University Hospital, Lund University, Sweden

Search for other papers by Pia Burman in
Google Scholar
PubMed Close
,
Olle Kämpe Department of Medicine (Solna), Centre for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden
Department of Endocrinology, Diabetes and Metabolism, Karolinska University Hospital, Stockholm, Sweden

Search for other papers by Olle Kämpe in
Google Scholar
PubMed Close
,
Eystein S Husebye Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Medicine, Haukeland University Hospital, Bergen, Norway

Search for other papers by Eystein S Husebye in
Google Scholar
PubMed Close
,
Stephanie Hahner Division of Endocrinology and Diabetes, University Hospital of Wuerzburg, Germany

Search for other papers by Stephanie Hahner in
Google Scholar
PubMed Close
,
Jette Kristensen Addison Foreningen i Danmark, Denmark

Search for other papers by Jette Kristensen in
Google Scholar
PubMed Close
,
Alida Noordzij AdrenalNET, The Netherlands

Search for other papers by Alida Noordzij in
Google Scholar
PubMed Close
, and
Per Dahlqvist Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

Search for other papers by Per Dahlqvist in
Google Scholar
PubMed Close

Injectable hydrocortisone. Box 2 Injectable hydrocortisone is available in only 85% of responding European countries (alternative names Hydrocortisone, Solucortef, Flebocortid, Actocortina, Corhydron). A few countries have methylprednisolone

Article Type:
Review Article
Collections:
Adrenal
DOI:
https://doi.org/10.1530/EC-22-0345
Volume/Issue:
Volume 12: Issue 1
Open access
Angelica Sharma Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Angelica Sharma in
Google Scholar
PubMed Close
,
Katharine Lazarus Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Katharine Lazarus in
Google Scholar
PubMed Close
,
Deborah Papadopoulou Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Deborah Papadopoulou in
Google Scholar
PubMed Close
,
Hemanth Prabhudev Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Hemanth Prabhudev in
Google Scholar
PubMed Close
,
Tricia Tan Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Department of Clinical Biochemistry, North West London Pathology, London, UK

Search for other papers by Tricia Tan in
Google Scholar
PubMed Close
,
Karim Meeran Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Karim Meeran in
Google Scholar
PubMed Close
, and
Sirazum Choudhury Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Department of Clinical Biochemistry, North West London Pathology, London, UK

Search for other papers by Sirazum Choudhury in
Google Scholar
PubMed Close

not available, an identical dose of prednisone can be used. This should not be confused with methylprednisolone, which is 20% more potent than both prednisolone and prednisone. It is important to note therefore that 4 mg methylprednisolone is

Article Type:
Research Article
Collections:
Adrenal
DOI:
https://doi.org/10.1530/EC-23-0097
Volume/Issue:
Volume 12: Issue 8
Open access
Jakub Supronik Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland

Search for other papers by Jakub Supronik in
Google Scholar
PubMed Close
,
Małgorzata Szelachowska Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland

Search for other papers by Małgorzata Szelachowska in
Google Scholar
PubMed Close
,
Adam Kretowski Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland
Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland

Search for other papers by Adam Kretowski in
Google Scholar
PubMed Close
, and
Katarzyna Siewko Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland

Search for other papers by Katarzyna Siewko in
Google Scholar
PubMed Close

, rituximab; SAE, serious adverse events; TRAb, thyroid receptor antibodies. A study by Salvi et al . (which will be referred to as the Italian study) compared RTX to i.v. pulses of methylprednisolone in the treatment of patients with active

Article Type:
Review Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-22-0303
Volume/Issue:
Volume 11: Issue 12
Open access